CEO & Co-founder of NeuroBell, a medical device company developing newborn brain monitoring solutions. Mark led the commercialisation of NeuroBell from PhD and Postdoctoral research, through to clinical trial and spinout.NeuroBell develops innovative products for early detection and monitoring of neonatal seizures to facilitate better treatment and improved patient outcomes. Our team is dedicated to developing cutting-edge technology that can help make a difference in the lives of patients and their families.